Monday, life sciences company Millipore Corp. (MIL) announced entering into an agreement to buy Guava Technologies, a provider of bench top cell analysis systems for $22.6 million.
Millipore expects the transaction to slightly add to its Non-GAAP earnings in fiscal 2009, and to close in the next two weeks.
Hayward, California-based Guava Technologies is the manufacturer of the commercial microcapillary flow cytometry system, which enables scientists to conduct flow cytometry using a small, bench top instrument.
Jonathan DiVincenzo, the president of Millipore's Bioscience Division stated, "Our vision is to make flow cytometry less expensive, easier to use, and more accessible for all research scientists."
MIL is currently trading up 30 cents at $55.46.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.